Conditions: Normal Tension Glaucoma Ocular Hypertension
Keywords: Glaucoma Ocular hypertension
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 32
Healthy volunteers: no

Brief summary:
The purpose of this study is to investigate IOP reduction efficacy of travoprost 0.004% ophthalmic solution (TRAVATAN Z®) in subjects with normal tension glaucoma.

Detailed description:

Arms:
arm 1: Travoprost Ophthalmic Solution 0.004%, 1 drop instilled in each eye once daily at 9PM for 3 months.

Interventions: intervention 1: Travoprost Ophthalmic Solution 0.004%
Intervention descriptions: intervention 1: benzalkonium chloride (BAC) free

Protocol document: